Development of Zika Virus DNA Vaccine Using Envelope Modified Baculoviral Gene Delivery System
Zika virus (ZIKV) is a mosquito-borne flavivirus and the infection of pregnant women can cause a wide range of congenital abnormalities, including microcephaly in the infant. However, there is no vaccine available yet. In this study, we intended to use PrM/E, which is the main target gene of neutral...
Main Authors: | Hanul Choi, Yuyeon Jang, Hansam Cho, Ha Youn Shin, Young Bong Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Proceedings |
Subjects: | |
Online Access: | https://www.mdpi.com/2504-3900/50/1/85 |
Similar Items
-
The Safe Baculovirus-Based PrM/E DNA Vaccine Protected Fetuses Against Zika Virus in A129 Mice
by: Hanul Choi, et al.
Published: (2021-04-01) -
Zika virus: Vaccine initiatives and obstacles
by: Reema Mukherjee, et al.
Published: (2017-01-01) -
Human endogenous retrovirus-enveloped baculoviral DNA vaccines against MERS-CoV and SARS-CoV2
by: Hansam Cho, et al.
Published: (2021-03-01) -
Pushing Forward With Zika Vaccines
by: Richard B. Kennedy
Published: (2016-11-01) -
Production of mosquito cell-derived Zika virus-like particles using BacMos system
by: Hui-Tsu Lin, et al.
Published: (2021-01-01)